Literature DB >> 12750235

Association of markers of insulin and glucose control with subsequent colorectal cancer risk.

Sharon H Saydah1, Elizabeth A Platz, Nader Rifai, Michael N Pollak, Frederick L Brancati, Kathy J Helzlsouer.   

Abstract

We evaluated the association of plasma insulin and other markers of insulin and glucose control with subsequent colorectal cancer. Incident colon (n = 132) and rectal (n = 41) cancer cases and matched controls (n = 346) were identified between baseline in 1989 and 2000 among participants in a community-based cohort in Washington County, Maryland. Circulating markers of insulin and glucose control were measured in baseline blood samples. Body mass index (BMI) and use of medications to treat diabetes mellitus were self-reported at baseline. Conditional logistic regression was used to estimate matched odds ratios (ORs). Compared with the lowest fourth, participants with insulin concentrations in the highest fourth were not at an increased risk of colorectal cancer [OR, 0.78; 95% confidence interval (CI), 0.45-1.35; P(trend) = 0.24]. Similarly, no associations were observed for the ratio of total cholesterol:HDL-cholesterol, triglycerides, and insulin-like growth factor binding protein 1. However, those in the highest fourth of glycosylated hemoglobin (HbA(1c)) level had a slightly increased risk of colorectal cancer (OR, 1.57; 95% CI, 0.94-2.60; P(trend) = 0.02). The OR of colorectal cancer was 1.70 (95% CI, 1.01-2.86; P(trend) = 0.08) comparing BMI >/=30 kg/m(2) to <25 kg/m(2). The OR of colorectal cancer was 2.43 (95% CI, 1.10-5.38) for the use of medications to treat diabetes. The associations of higher HbA(1c), higher BMI, and the use of medications to treat diabetes, with colorectal cancer lend support to the hypothesis that perturbations in insulin and glucose control may influence colorectal carcinogenesis. It is possible that HbA(1c), BMI, and the use of medications to treat diabetes, as a surrogate for protracted or severe type 2 diabetes mellitus, may have been better time-averaged indicators of hyperinsulinemia and hyperglycemia than the plasma markers that were measured once prediagnostically in a nonfasting population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750235

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  73 in total

1.  Glycemic index and colorectal carcinogenesis.

Authors:  Edward Giovannucci
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 2.  Diabetes mellitus is an independent risk factor for colorectal cancer.

Authors:  Lei Sun; Shiying Yu
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

3.  Hemoglobin A1c concentrations and risk of colorectal cancer in women.

Authors:  Jennifer Lin; Paul M Ridker; Aruna Pradhan; I-Min Lee; JoAnn E Manson; Nancy R Cook; Julie E Buring; Shumin M Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

4.  Diabetes, insulin and cancer risk.

Authors:  Xi-Lin Yang; Juliana Cn Chan
Journal:  World J Diabetes       Date:  2012-04-15

5.  Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study.

Authors:  Ali A Siddiqui; Stuart J Spechler; Sergio Huerta; Serag Dredar; Bertis B Little; Byron Cryer
Journal:  Dig Dis Sci       Date:  2008-04-12       Impact factor: 3.199

6.  Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.

Authors:  Konstantinos K Tsilidis; Frederick L Brancati; Michael N Pollak; Nader Rifai; Sandra L Clipp; Judith Hoffman-Bolton; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-09-23       Impact factor: 2.506

Review 7.  Diabetes and cancer: Associations, mechanisms, and implications for medical practice.

Authors:  Chun-Xiao Xu; Hong-Hong Zhu; Yi-Min Zhu
Journal:  World J Diabetes       Date:  2014-06-15

8.  Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.

Authors:  Cheryl Ritenbaugh; Janet L Stanford; LieLing Wu; James M Shikany; Robert E Schoen; Marcia L Stefanick; Vicky Taylor; Cedric Garland; Gail Frank; Dorothy Lane; Ellen Mason; S Gene McNeeley; Joao Ascensao; Rowan T Chlebowski
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09-30       Impact factor: 4.254

9.  Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men.

Authors:  Masafumi Tabuchi; Joji Kitayama; Hirokazu Nagawa
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.